Health Catalyst (HCAT)
(Real Time Quote from BATS)
$3.77 USD
-0.05 (-1.31%)
Updated Aug 6, 2025 10:20 AM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2025
Time: AMC |
6/2025 | $0.03 | 0.00% |
Earnings Summary
For their last quarter, Health Catalyst (HCAT) reported earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for HCAT's next earnings release on August 07, 2025. For the next earning release, we expect the company to report earnings of $0.03 per share, reflecting a year-over-year decrease of 75%.
Earnings History
Price & Consensus
Zacks News for HCAT
VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait?
HCAT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?
Health Catalyst (HCAT) Upgraded to Buy: Here's Why
Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
HCAT FAQs
Health Catalyst, Inc. (HCAT) has announced they will report their next quarter earnings on August 07, 2025. For the next earning release, we expect the company to report earnings of $0.03 per share, reflecting a year-over-year decrease of -75.00%.
Health Catalyst, Inc. has announced they will report their previous quarter earnings after the close of the market on August 07, 2025.
The Zacks Consensus Estimate for Health Catalyst, Inc. (HCAT) for the quarter ending June 2025 is $0.03 a share. We expect Health Catalyst, Inc. (HCAT) to report earnings in line with the consensus estimate of $0.03 per share
In the earnings report for the quarter ending in June 2024, Health Catalyst, Inc. (HCAT) announced earnings of $0.12 per share versus the Zacks Consensus Estimate of $0.09 per share, representing a surprise of 33.33%.